Order Article Reprints

Baranašić J, Šutić M, Catalano C, Drpa G, Huhn S, Majhen D, Nestić D, Kurtović M, Rumora L, Bosnar M, et al. TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. Biomedicines. 2022; 10(9):2240. https://doi.org/10.3390/biomedicines10092240

Baranašić, Jurica, Maja Šutić, Calogerina Catalano, Gordana Drpa, Stefanie Huhn, Dragomira Majhen, Davor Nestić, Matea Kurtović, Lada Rumora, Martina Bosnar, and et al. 2022. "TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line" Biomedicines 10, no. 9: 2240. https://doi.org/10.3390/biomedicines10092240

Baranašić, J., Šutić, M., Catalano, C., Drpa, G., Huhn, S., Majhen, D., Nestić, D., Kurtović, M., Rumora, L., Bosnar, M., Vukić Dugac, A., Sokolović, I., Popovic-Grle, S., Oršolić, N., Škrinjarić-Cincar, S., Jakopović, M., Samaržija, M., Weber, A. N. R., Försti, A., & Knežević, J. (2022). TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. Biomedicines, 10(9), 2240. https://doi.org/10.3390/biomedicines10092240